The Impact of intraoperative fibrinogen replacement therapy on the clinical outcome of surgical therapy for type A acute aortic dissection

In the surgical treatment of ATAAD, FRT increases fibrinogen levels by approximately 71 mg/dL, achieving adequate hemostasis without increasing adverse outcomes. Additionally, FC is effective in reducing postoperative blood loss in patients with a bleeding tendency whose fibrinogen level is below 150 mg/dL before weaning from cardiopulmonary bypass.